EUVIMEDEUVIMED entdecken
Crossref

Dan-shen Yin attenuates myocardial fibrosis after myocardial infarction in rats: Molecular mechanism insights by integrated transcriptomics and network pharmacology analysis and experimental validation

Xuan Gao, Chenyang Ni, Yingying Song, Xueqing Xie, Sitong Zhang, Yufeng Chen, Hui Wu, Hailian Shi, Beibei Zhang, Fei Huang, Changhong Wang, Xiaojun Wu

Journal of Ethnopharmacology · 2025

DOI: 10.1016/j.jep.2024.119070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Ethnopharmacology, 2025. Verfasst von Xuan Gao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The M…. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Myocardial Infarction, Fibrosis, Network Pharmacology. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

ETHNOPHARMACOLOGICAL RELEVANCE: Dan-shen Yin (DSY) originated from the "Shi Fang Ge Kuo" is a Chinese formula composed of three medicines: Salvia miltiorrhiza (Dan-shen), Santalum album L. (Tan-xiang) and Amomum villosum Lour. (Sha-ren). It has many years of clinical experience in the prevention of myocardial fibrosis (MF). However, the specific mechanism of DSY in prevent MF is not clear. AIM OF THE STUDY: This study aimed to assess the efficacy of DSY in the prevention of MF and reveal its underlying mechanism in a rat model of MF after myocardial infarction (MI) induced by ligation of the left anterior descending branch (LAD) of the coronary artery. MATERIALS AND METHODS: The blood-entry components of DSY were analyzed by UHPLC-Q-TOF-MS/MS. LAD-ligated rats were used to assess the efficacy of DSY in the prevention of MF. Network pharmacology and transcriptomics analysis were used to predict possible target signaling pathways of DSY in MF. Echocardiography, immunohistochemistry and ELISA methods were used to evaluate the cardiac functions and biochemical changes of the rats. The mRNA expressions of target genes were measured by RT-qPCR. The proteins expressions, including Collagen I, Collagen III, α-smooth muscle actin (α-SMA), matrix metallopeptidase 2 (MMP 2), matrix metallopeptidase 9 (MMP 9), transforming growth factor-β (TGF-β), protein kinase B (AKT), phospho-AKT, extracellular regulated protein kinases (ERK), phospho-ERK, c-Jun N-terminal kinase (JNK), phospho-JNK, mothers against decapentaplegic protein (Smad3), and phospho-Smad3 were detected and quantified by Western Blot. RESULTS: UHPLC-Q-TOF-MS/MS analysis disclosed that 20 components within DSY could be absorbed into blood of rats. DSY improved myocardial injury in the myocardial tissue of LAD-ligated rats, as evidenced by the elevation of left ventricular ejection fraction and left ventricular fractional shortening, and the decrease of the serum CK-MB and LDH levels. Network pharmacology and transcriptomics predicted that DSY could interfere biological processes, such as extracellular matrix organization, focal adhesion and ECM-receptor interaction, and modulate TGF-β mediated signaling pathways, including PI3K/AKT, MAPK, and Smad3. Further study confirmed that DSY reduced MF, accompanied by reduced TGF-β, Collagen I, Collagen III, α-SMA, MMP 2 and MMP 9. Moreover, DSY repressed the phosphorylation of AKT, MAPKs and Smad3. In addition, DSY reduced inflammation and suppressed the mRNA expressions of IL-1β, IL-6, TNF-α, COX2 and iNOS in MF rats. CONCLUSIONS: Our study demonstrated that DSY prevented MF in vivo, the action of which was probably via reducing extracellular matrix organization, focal adhesion ECM-receptor interaction and inflammation by regulating TGF-β mediated PI3K/AKT, MAPK and Smad signaling pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Drugs, Chinese HerbalMyocardial InfarctionFibrosisNetwork PharmacologyRats, Sprague-DawleyAnimalsMaleRatsMyocardiumTranscriptomeSignal TransductionDisease Models, AnimalGene Expression Profiling

Stichwörter der Autor:innen

Dan-shen YinMyocardial fibrosisMyocardial infarctionNetwork pharmacologyTGF-β signaling pathwayTranscriptomics

Substanzen

Drugs, Chinese Herbal

Autor:innen und Institutionen

  • Shanghai Key Laboratory of Compound Chinese Medicines, The Ministry of Education (MOE) Key Laboratory for Standardization of Chinese Medicines, The MOE Innovation Centre for Basic Medicine Research on Qi-Blood TCM Theor…

Zitieren

APA

Gao, X., Ni, C., Song, Y., Xie, X., Zhang, S., Chen, Y., Wu, H., Shi, H., Zhang, B., Huang, F., Wang, C., & Wu, X. (2025). Dan-shen Yin attenuates myocardial fibrosis after myocardial infarction in rats: Molecular mechanism insights by integrated transcriptomics and network pharmacology analysis and experimental validation. Journal of Ethnopharmacology. https://doi.org/10.1016/j.jep.2024.119070

Vancouver

Gao X, Ni C, Song Y, Xie X, Zhang S, Chen Y, et al. Dan-shen Yin attenuates myocardial fibrosis after myocardial infarction in rats: Molecular mechanism insights by integrated transcriptomics and network pharmacology analysis and experimental validation. Journal of Ethnopharmacology. 2025. doi:10.1016/j.jep.2024.119070

BibTeX
@article{Gao2025,
  author = {Gao, Xuan and Ni, Chenyang and Song, Yingying and Xie, Xueqing and Zhang, Sitong and Chen, Yufeng and Wu, Hui and Shi, Hailian and Zhang, Beibei and Huang, Fei and Wang, Changhong and Wu, Xiaojun},
  title = {Dan-shen Yin attenuates myocardial fibrosis after myocardial infarction in rats: Molecular mechanism insights by integrated transcriptomics and network pharmacology analysis and experimental validation},
  journal = {Journal of Ethnopharmacology},
  year = {2025},
  doi = {10.1016/j.jep.2024.119070}
}
Kostenlos starten →